Skip to main navigation Skip to search Skip to main content

In vitro and in vivo activity of R547: A potent selective cyclin-dependent kinase inhibitor currently in phase I clinical trials

  • Wanda DePinto
  • , Xin Jie Chu
  • , Melissa Smith
  • , Kathryn Packman
  • , Petra Goelzer
  • , Allen Lovey
  • , Yingsi Chen
  • , Hong Qian
  • , Rachid Hamid
  • , Qing Xiang
  • , Christian Tovar
  • , Roger Blain
  • , Tom Nevins
  • , Brian Higgins
  • , Leopoldo Luistro
  • , Kenneth Kolinsky
  • , Bernardo Felix
  • , Sazzard Hussain
  • , David Heimbrook

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'In vitro and in vivo activity of R547: A potent selective cyclin-dependent kinase inhibitor currently in phase I clinical trials'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science